Ilya B. Tsyrlov, MD, has completed his PhD in Biochemistry at the age of 27 and thereafter – a DSci in Molecular Toxicology. He has been working as Group leader, Head of the laboratory, Department chair at Russian Academy of Science. In the United States, served as a Senior Scientist at NCI, NIH, and Professor at Mount Sinai School of Medicine. Since 2005, a president/CSO of XENOTOX Inc, USA. Incepted and developed the Xenobiotical Virology as an interdisciplinary biomedical field. He is the author of 4 monographs and 250+ peer reviewed publications, and has been serving as an editorial board member of reputed Journals.

Biochemistry & Virology

I am an experienced Researcher Assistant of Medical Microbiology and Immunology and Infection Control Practitioner undertaking scientific research into microorganisms with the aim of identifying new ways of diagnosing, treating and preventing infectious diseases at Theodor Bilharz Research Institute, Egypt. I am skilled and interested in Anti-microbial resistance, Molecular and Immunological diagnosis of infectious diseases, Academic Teaching and Research, Patient Safety and Healthcare Quality. I am a member in the Presidential Leadership Program, a project under patronage of the Presidency of Arab Republic of Egypt to create an enlightened capable caliber of young leaders, with strong skills in blend of Social Science, Governance, Public Administration, Entrepreneurship, Politics and National Security. I have been honored by the award of Best Speech at the 5th International Scientific Conference held in Yerevan State University, Armenia 2018. My goal is to expand my expert horizon in skills of scientific integrity and to gain more scientific experience through working in projects characterized by challenging new ideas and the need for leadership skills.

Medical Microbiology, Immunology and Infection Control

Priya, a synthetic biologist and biochemist by training, is developing high throughput assay platforms at Arbor. Prior to joining Arbor, Priya did her post-doctoral work at MIT, where her work was focused on phage engineering and building phagemid based synthetic biology tool kits for pathway engineering and recombinase based state machines. She obtained her Ph.D. in Pharmacognosy and Biotechnology from University of Illinois at Chicago (UIC) where she studied the mechanism of antibiotic dependent arrest of protein synthesis to understand the action of antibiotics and antibiotic resistance at a molecular level enabling discovery of novel antibiotics. She received her B. Tech in Industrial Biotechnology from Anna University, India and is a recipient of the Khorana Fellowship in 2009.

Pharmacognosy and Biotechnology

Dr. Joshi is an adjunct professor at the A.J. Drexel Plasma Institute, as well as Drexel's School of Biomedical Engineering. He has a special interest in emerging bacterial infections, disinfection and sterilization, and biodefense. Since 1987, Dr. Joshi has taught undergraduate, postgraduate and doctoral students and trained doctoral and postdoctoral fellows in research. He has been mentoring graduates and medical students, who now have successful careers in medicine, academia and the pharmaceutical industry. Since 2004, he has been a member of international mentoring program and minority mentoring program of American Society of Microbiology (ASM), and Infectious Disease Society of America (IDSA).

Bacterial pathogenesis and biofilms; wound infection and healing

I am the lead pathologists’ assistant (PA) certified by the American Society for Clinical Pathology (ASCP) with a master of health science degree appointed for 9 years as an instructor at Baylor College of Medicine (BCM) and a clinical adjunct professor of Quinnipiac University’s Pathologists’ Assistant Program. My clinical work includes recognizing and sampling macroscopic disease within surgical pathology specimens postoperatively or during surgical intraoperative consultation at Ben Taub General Hospital. Occasionally, I cover St. Joseph Medical Center and BCM’s West Belfort lab in this capacity. With optimal patient care as my goal, I decrease the workload of the pathologists and residents who I simultaneously teach by leading through example. After observing and assessing various pathology trainees, including fellows, pathologists’ assistant students, medical students and shadowing undergraduates, I developed a passion to strengthen both pathology residency and pathologists’ assistant programs which is reflected in my curriculum development efforts. For example, by request of the residents, I conduct monthly Interesting Gross Case Workshops currently teleconferenced at a national level to two PA programs. I received Spring 2016’s Fulbright and Jaworski Faculty Excellence Award in Teaching Evaluation verifying the quality and quantity of my educational efforts. Because literature and statistics expose gaps in pathology residency education and dwindling interest to enter the pathology field by medical students, I created and directed the 2017 All-City Anatomic Pathology Symposium sponsored by BCM, which introduced the field of pathology to medical students and undergraduates and offered recapitulation to residents and fellows and ASCP CMLE credits to PAs. The symposium fostered citywide collaborative teaching platforms for pathologists and PAs. The planning committee was comprised of academic PAs-members of the local PA professional organization, Pathassist of Texas in Houston, LLC, founded and presided by myself. While planning this academic feat, American Association of Pathologists’ Assistants offered me speaking engagements for 2 consecutive years and requested my help to incorporate academic PA education into their educational plan. My suggestions produced roundtable discussion groups/workshops for 2 annual conferences. While revolutionizing the PA field as a respected and recognized academic resource for pathology learners, as an example to my colleagues, I strengthened my faculty portfolio by expanding my research and scholarly efforts, an area of weakness for PAs. I designed five research projects with 4 receiving IRB approval. I serve as a first author on four manuscripts with one accepted and one published. In addition, I am a PI for Baylor College of Medicine Tissue Resource, TCGA Tissue Source Repository Tissue Source Site for Clinical and Proteomic Tumor Analysis Consortium (CPTAC) Phase III funded by National Institute of Health, Genome Research Institute and National Cancer Institute. To further implement changes in pathology education, I am a resident in the 6th cohort for the University of Houston’s Executive Doctorate in Professional Leadership Program (EdD) which focuses upon educational needs in medicine and problem-solving strategies through intensive research, thus continuing BCM’s mission of improving health through science, innovation, teamwork and excellence.

Pathology